慢性リンパ球性白血病(CLL):世界の臨床試験レビュー(2014年上半期)...市場調査レポートについてご紹介

【英文タイトル】Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H1, 2014

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Chronic Lymphocytic Leukemia (CLL) 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Chronic Lymphocytic Leukemia (CLL) to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Chronic Lymphocytic Leukemia (CLL) to Oncology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Chronic Lymphocytic Leukemia (CLL) 25
Subjects Recruited Over a Period of Time 35
Clinical Trials by Sponsor Type 36
Prominent Sponsors 37
Top Companies Participating in Chronic Lymphocytic Leukemia (CLL) Therapeutics Clinical Trials 38
Prominent Drugs 40
Latest Clinical Trials News on Chronic Lymphocytic Leukemia (CLL) 41
Jan 07, 2014: Independent Data Monitoring Committee Recommends Early Stopping of Phase 3 Study of Ibrutinib in Relapsed/Refractory CLL/SLL Patients Based on a Planned Interim Analysis 41
Dec 10, 2013: MorphoSys Announces Additional Clinical Trial of MOR208 42
Dec 10, 2013: Emergent BioSolutions’ Otlertuzumab (TRU-016) Shows Positive Results in Combination with Rituximab in People with CLL 42
Dec 08, 2013: Infinity Reports Updated Phase 1 Data Showing Encouraging Clinical Activity of IPI-145 in Chronic Lymphocytic Leukemia and T-Cell Lymphoma at ASH Annual Meeting 43
Dec 07, 2013: Gilead Announces Interim Phase 2 Results for GS-9973 in Previously Treated Chronic Lymphocytic Leukemia 45
Clinical Trial Profiles 46
Clinical Trial Overview of Top Companies 46
F. Hoffmann-La Roche Ltd. 46
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 46
Celgene Corporation 52
Clinical Trial Overview of Celgene Corporation 52
GlaxoSmithKline plc 57
Clinical Trial Overview of GlaxoSmithKline plc 57
Pharmacyclics, Inc. 61
Clinical Trial Overview of Pharmacyclics, Inc. 61
Sanofi 64
Clinical Trial Overview of Sanofi 64
Bayer AG 66
Clinical Trial Overview of Bayer AG 66
Gilead Sciences, Inc. 68
Clinical Trial Overview of Gilead Sciences, Inc. 68
Johnson & Johnson 70
Clinical Trial Overview of Johnson & Johnson 70
AbbVie Inc. 72
Clinical Trial Overview of AbbVie Inc. 72
Clinical Trial Overview of Top Institutes / Government 74
National Cancer Institute 74
Clinical Trial Overview of National Cancer Institute 74
The University of Texas M. D. Anderson Cancer Center 83
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 83
Fred Hutchinson Cancer Research Center 87
Clinical Trial Overview of Fred Hutchinson Cancer Research Center 87
Memorial Sloan Kettering Cancer Center 90
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 90
National Heart, Lung, and Blood Institute 92
Clinical Trial Overview of National Heart, Lung, and Blood Institute 92
Mayo Clinic 93
Clinical Trial Overview of Mayo Clinic 93
Masonic Cancer Center 94
Clinical Trial Overview of Masonic Cancer Center 94
University of California, San Diego 95
Clinical Trial Overview of University of California, San Diego 95
Eastern Cooperative Oncology Group 96
Clinical Trial Overview of Eastern Cooperative Oncology Group 96
Five Key Clinical Profiles 97
Appendix 196
Abbreviations 196
Definitions 196
Research Methodology 197
Secondary Research 197
About GlobalData 198
Contact Us 198
Disclaimer 198
Source 199


【レポート販売概要】

■ タイトル:慢性リンパ球性白血病(CLL):世界の臨床試験レビュー(2014年上半期)
■ 英文:Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H1, 2014
■ 発行日:2014年3月12日
■ 調査会社:GlobalData
■ 商品コード:GDHC2022CTIDB
■ 調査対象地域:グローバル
  • グローバル及び地域メガトレンド:「トラスト(信頼)」における消費者態度及び行動の理解
    Summary “Global and Regional Mega-Trends: Understanding Consumer Attitudes and Behaviors in Trust' examines how and why people are becoming less trusting of the practices and activities of brands and corporations. The report focuses on how traceability is more important than ever when it comes to protecting brand share and what strategies brands can engage to maximise perceptions of trust over the …
  • 心臓バイオマーカーの世界市場:トロポニン、BNP/NT-proBNP、CK-MB、ミオグロビン
    About Cardiac Biomarker A cardiac biomarker is defined as a measurable substance that is an indicator used in the diagnosis and risk stratification related to cardiovascular disease (CVDs) such as acute coronary syndrome (ACS), coronary syndromes, myocardial infarction (MI), and heart failure. Some of the cardiac biomarkers include creatine kinase (CK) MB, troponins (cTnI and cTnT), BNP, NT-proBNP …
  • 世界の油圧モーターおよびエンジン市場(~2019)
    The expansion of the global hydraulic power motor and engine industry is forecast to reach 5.0% p.a. in the coming years. Between 2008 and 2014 the market increased with an average annual growth of 7.2%. Currently, linear acting hydraulic power motors and engines account for 53.4% of the global demand while other hydraulic power motors and engines have a 46.6% share of the market. Canada, China, G …
  • 自動車AR(拡張現実)の世界市場2016-2020
    About the Automotive Augmented Reality Market Need for AR: Deficits of existing HUDs HUDs have been around since the late 1980s, when General Motors (GM) used it in their Oldsmobile. However, the principal reason for having HUDs, which is to reduce the need of the driver to look away from the road, never changed. Primary deficiencies of conventional HUDs • Irrelevant information and on-screen spac …
  • 世界の自動車内装材市場:綿、アクリル、レーヨン、人造繊維、ビニール、革など
    About Automotive Upholstery Automotive upholstery is a soft furnishing covering that is fixed to an automobile seat. To keep it soft, automotive upholstery is padded with foam with thickness ranging from 0.12 inches to 0.39 inches. Automotive upholsterers are also known as trimmers, motor trimmers, or coach trimmers. The Global Automotive Upholstery market is highly dependent on the Automobile ind …
  • Atopic Dermatitis:グローバル臨床試験レビューH1, 2013
    Atopic Dermatitis Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Atopic Dermatitis Global Clinical Trials Review, H1, 2013" provides data on the Atopic Dermatitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Atopic Dermatitis. It includes an overview of the trial numbers and their recruitment s …
  • ゼインの世界市場
    Zein (CAS 9010-66-6) Market Research Report 2013 presents comprehensive data on zein markets globally and regionally (Europe, Asia, North America etc.) The Zein (CAS 9010-66-6) Market Research Report 2013 includes zein description, covers its application areas and related patterns. It overviews zein market, names zein producers and indicates its suppliers. Besides, the Zein (CAS 9010-66-6) Market …
  • マイクログリッドの世界市場:グリッドコネクテッド型、リモート/アイランド型、ハイブリッド型
    The microgrid market is estimated to reach USD 34.94 Billion by 2022, at a CAGR of 10.9% between 2016 and 2022. Growing demand for scalable and economic grid controls, cheap and clean energy storage options, and shift towards remote grids in the military segment are the factors driving the microgrid market positively. Among the grid-types available, remote grid-type is expected to grow at the high …
  • 肝性脳症(Hepatic Encephalopathy):世界の治験レビュー(2015年上半期版)
    Hepatic Encephalopathy Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Hepatic Encephalopathy Global Clinical Trials Review, H1, 2015" provides data on the Hepatic Encephalopathy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hepatic Encephalopathy. It includes an overview of the trial numbers and …
  • 高調波フィルタの世界市場2018-2022
    116 pages, November 2018 About this market The rising investments in renewable energy to trend in the market. Resources available for industries across the world are limited as most government has imposed strict regulations to control the use of resources. Consumers are also motivated to use eco-friendly products. Technavio’s analysts have predicted that the harmonic filters market will register a …
  • メチレンDi-P-フェニレンイソシアン酸塩(MDI)の世界市場予測
    Methylene di-p-phenylene isocyanate 2014 World Market Outlook and Forecast is an absolutely essential resource for anyone looking for detailed information on the mentioned market. Using a wide range of primary and secondary sources, we combined, analyzed and presented all available data about methylene di-p-phenylene isocyanate market in the all-in-one report issued in a logical and easily accessi …
  • 活性炭の世界市場:粒状活性炭、粉末状活性炭、ペレット状活性炭
    About Activated Carbon Market Activated carbon is an organic material with a high content of carbon such as wood, coal, wood, and coconut shells. The activation process involves carbonization of raw materials followed by thermal decomposition, which leads to the development of porosity and, thus, a high adsorption power. Activated carbon is used in a wide range of applications that primarily invol …
  • ITアウトソーシングの世界市場:アプリケーションアウトソーシング、インフラアウトソーシング
    IT outsourcing is the process of subcontracting the IT functions of an organization to a third-party vendor that has expertise in the required domains. It is an effective strategy to build a high-performance IT organization. IT outsourcing services are helping organizations to manage their IT function through their IT expert team and innovative technologies. C-suite executives of companies have wi …
  • ランニングアパレル/フットウェアの世界市場
    About Running Apparel and Footwear Running is considered to be the best exercise form as it helps in maintaining a healthy body weight. Running got popular in the late 1960s in North America and hit in Europe in the 1980s. In the recent years, the growing number of running events such as marathons in emerging economies has influenced the demand for running apparel and footwear. Major vendors are c …
  • グルメソルト(Gourmet Salt)のグローバル市場動向(~2019)
    Gourmet salts are used in cuisines that demand extravagance and appeal. Gourmet cooks use these salts as seasoning and dressing. Gourmet salts are used as enhancers of texture, appeal and taste, as against to simply blending with the food giving an everyday-flavor. These salts have better solubility, exotic flavor, moisture, and higher mineral content. The increasing living standard of the consume …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。